0001367644-23-000109.txt : 20230530
0001367644-23-000109.hdr.sgml : 20230530
20230530190918
ACCESSION NUMBER: 0001367644-23-000109
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230525
FILED AS OF DATE: 20230530
DATE AS OF CHANGE: 20230530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: White Marvin L
CENTRAL INDEX KEY: 0001493324
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 23978441
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
wk-form4_1685488148.xml
FORM 4
X0407
4
2023-05-25
0
0001367644
Emergent BioSolutions Inc.
EBS
0001493324
White Marvin L
400 PROFESSIONAL DRIVE
GAITHERSBURG
MD
20879
1
0
0
0
0
Common Stock
2023-05-25
4
A
0
33847
0
A
50949
D
Consists of restricted stock units granted under the company's Stock Incentive Plan, as amended and restated. These restricted stock units vest in one installment beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
/s/ Richard S. Lindahl, Attorney-in-fact
2023-05-30